Mark Lovern Joins In Silico Trials As Chief Platform Officer
10/17/23, 12:07 PM
Location
Industry
it services and it consulting
Position
chief platform officer
Today, InSilicoTrials warmly welcomes Dr. Mark Lovern in his new role as Chief Platform Officer, a move marking the company's continued commitment to leading the frontier of AI-driven innovation and simulation in life sciences.
Company Info
Location
wilmington, delaware, united states
Additional Info
We are a game-changer in the life sciences sector. Our mission is to hyper-accelerate drug and medical device development leveraging top notch technology like Modeling and Simulation and Artificial Intelligence.
We are an international team of professionals coming from healthcare, regulatory, engineering simulation, IT, cloud, and cybersecurity.
We work with a network of 70+ prestigious universities and research centers worldwide and we are currently part of 5 EU-funded projects that are really making a difference in healthcare: SimCardioTest, Brainteaser, In Silico World, Disc4All and TranSys.
Our unique cloud platform offers Pharma and MedTech companies state-of-the-art simulation tools that can highly reduce the cost and time of medical products development, while increasing their safety and efficacy. We are endorsed by top international regulators such as FDA and EMA., that have been encouraging for years the adoption of in silico methods in healthcare.